StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Petros Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$3.72M. For fiscal 2025 it was -$6.73M. The highest annual figure on record is -$2.60M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.73M–
FY2024Dec 31, 2024-$2.60M–
FY2023Dec 31, 2023-$7.63M–
FY2022Dec 31, 2022-$12.80M–
FY2021Dec 31, 2021-$11.86M–
FY2020Dec 31, 2020-$15.31M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$863.86K–
Q1 FY2026Mar 31, 2026-$784.27K–
Q4 FY2025Dec 31, 2025-$933.54K-196.7%
Q3 FY2025Sep 30, 2025-$1.13M–
Q2 FY2025Jun 30, 2025-$3.01M–
Q1 FY2025Mar 31, 2025-$1.66M–
Q4 FY2024Dec 31, 2024$965.41K–
Q3 FY2024Sep 30, 2024-$771.25K–
Q2 FY2024Jun 30, 2024-$1.66M–
Q1 FY2024Mar 31, 2024-$1.13M–
Q4 FY2023Dec 31, 2023-$2.26M–
Q3 FY2023Sep 30, 2023-$4.05M–
Q2 FY2023Jun 30, 2023-$572.07K–
Q1 FY2023Mar 31, 2023-$748.36K–
Q4 FY2022Dec 31, 2022-$1.57M–
Q3 FY2022Sep 30, 2022-$1.75M–
Q2 FY2022Jun 30, 2022-$4.20M–
Q1 FY2022Mar 31, 2022-$5.28M–
Q2 FY2021Jun 30, 2021-$1.90M–
Q1 FY2021Mar 31, 2021-$446.58K–
Q4 FY2020Dec 31, 2020-$4.52M–
Q3 FY2020Sep 30, 2020-$2.67M–
Q2 FY2020Jun 30, 2020-$5.74M–
Q1 FY2020Mar 31, 2020-$2.38M–

More Petros Pharmaceuticals figures

See a number that looks wrong?